Belderbos, Bodine P. S.
de With, Mirjam
Singh, Rajbir K.
Agema, Bram C.
El Bouazzaoui, Samira
Oomen-de Hoop, Esther
de Wit, Ronald
van Schaik, Ron H. N.
Mathijssen, Ron H. J.
Bins, Sander https://orcid.org/0000-0002-8280-9836
Article History
Received: 29 July 2019
Accepted: 7 December 2019
First Online: 1 January 2020
Compliance with ethical standards
:
: Bodine Belderbos has received travel support from Astellas. Ronald de Wit has received advisory fees from Sanofi, Merck, Lilly, Roche, Bayer, Janssen, and Clovis. He has received speaker fees from Sanofi and Merck and research funding (Institutional) from Sanofi and Bayer. Ron Mathijssen has received research funding (Institutional) from Sanofi and Astellas. The other authors declare that they have no conflict of interest.
: Informed consent was obtained from all individual participants included in this article.